MKI67 and breast carcinoma: In the subgroup analysis of low-aggressive tumors, specifically early-stage breast cancer with negative lymph nodes, patients with high Ki-67 levels showed significantly lower disease-free survival (DFS) compared to those with low Ki-67 levels.